SHANGHAI, Sept. 18, 2024 /PRNewswire/ — Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held in Shanghai from August 27 to 30, 2024, co-hosted by LeadLeo.

Based on the research and analysis of the global medical imaging foundation model in recent years, as well as the study and evaluation of related companies in the industry, Frost & Sullivan has awarded Hangzhou Diagens Biotechnology Co.,Ltd. the Global Medical Imaging Foundation Model Innovation Award at the GIL Summit and NIE 2024. Mr. Aroop Zutshi, the Global Managing Partner and Executive Board Member of Frost & Sullivan, and Professor Yu Wang, the Chairman of Chinese Foundation for Hepatitis Prevention and Control and the Former Director General of Chinese Center for Disease Control and Prevention presented this award to Mr. Chengfa Wu, the secretary to the board of Hangzhou Diagens Biotechnology Co.,Ltd.

Diagens independently developed the world’s leading generalized medical imaging model, and its achievements have been widely recognized

Hangzhou Diagens Biotechnology Co.,Ltd. ("Diagens") was founded in 2016, focusing on the core technology innovation of artificial intelligence in medical imaging. The company has independently developed the world’s leading generalized medical imaging model and has made significant achievements in the field of artificial intelligence medical imaging.

As China’s national-level specialized and innovative "Little Giant" enterprise, national technology-based enterprise, and national high-tech enterprise, Diagens has more than 60 core intellectual property rights in China, the United States and Europe, and its scientific and technological achievements have been widely recognized. Among them, the core products of Diagens’s artificial intelligence model for medical imaging have obtained 27 certificates from NMPA in China, CE in the EU and FDA in the US, and won the first prize in the Science and Technology Achievement Award of the China Birth Defects Intervention and Relief Foundation, as well as ranked the first in reproductive field in the "Artificial Intelligence Medical Devices" list of the China’s Ministry of Industry and Information Technology.

Diagens’s core technology catches up with overseas, setting a new benchmark for the industry

Relying on its deep technical accumulation and excellent innovation ability in the field of medical imaging, Diagens has successfully developed a large model on the medical imaging foundation, which has been applied to karyotype analysis. The system combines the core technology of AI imaging with precision optical equipment, and its world’s first third-generation karyotype analysis technology sets up a new benchmark of accuracy and efficiency in the industry. Through this innovative application, the industry’s accuracy benchmark has been raised from 50% to 99.45%, and the time for issuing clinical reports has been shortened from nearly 30 days to only 4 days, significantly improving the efficiency.

This breakthrough achievement of Diagens has established a new paradigm for global karyotype analysis and has obtained the International First-of-its-kind Equipment Certification. In addition, the technology has been evaluated by the China’s national expert group as an international leader in core technology, and the products have been sold to more than 400 China’s Grade A tertiary hospitals, providing strong support for clinical diagnosis and treatment.

Diagens continues to enhance its technological capabilities for the global medical imaging market

The medical imaging foundation large model of Diagens has now been successfully applied to the comprehensive solution of cytogenetic laboratory, which includes fully autonomous, whole process and fully intelligent cytogenetic diagnostic services, such as high-efficiency cultivation, automatic acquisition, automatic preparation, intelligent scanning, intelligent analysis, and online diagnosis. The solution is applicable to many fields such as prenatal diagnosis, assisted reproduction, hematology and oncology, radiation medicine and radiation safety.

In the future, Diagens will continue to increase the number of self-developed large models. Targeting the global medical imaging market worth hundreds of billions of dollars, Diagens plans to spend another 3-5 years achieving comprehensive technological leadership in various medical imaging sub-sectors. Through continuous innovation and breakthroughs, Diagens will be committed to providing more efficient and accurate diagnostic tools for patients and healthcare workers, and promoting the sustainable development of the medical imaging field.

About Frost & Sullivan’s Global Leadership Award

The Frost & Sullivan Global Leadership Award recognizes enterprises’ outstanding performance and exceptional achievements in areas such as technology innovation, market potential, customer service, branding, and others. The Frost & Sullivan team nominated a group of competitive and excellent enterprises through methods including in-depth interviews, industry analysis, and secondary research. An independent judging panel, made up of third-party investment and financing experts, financial experts, bankers, and renowned listed company entrepreneurs, conducted rigorous evaluations of the nominated enterprises and decided to grant the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd.

Source : Frost & Sullivan grants the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd.

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

PHU QUOC, Vietnam, Sept. 18, 2024 /PRNewswire/ — Receiving the prestigious award for "Asia’s Leading Family Beach Resort" from the World Travel Awards 2024, Premier Residences Phu Quoc is the perfect choice for a family year-end getaway on Phu Quoc island. At the resort, guests can truly "Live in Style" with vibrant entertainment activities designed for both parents and children.

Resort over view – Premier Residences Phu Quoc Emerald Bay

When staying at Premier Residences Phu Quoc, guests are treated to exclusive benefits within the Southern Phu Quoc ecosystem, offering truly unique experiences. One of the standout privileges is that all room rates at the resort include tickets to the "Kiss of The Sea" show and the spectacular fireworks display at Sunset Town — a multimedia masterpiece told through fire, water, light, lasers, and music, leading families into a fantastical world of wonder.

The exclusive privileges for guests at Premier Residences Phu Quoc Emerald Bay

From the resort, guests can take advantage of the complimentary shuttle service to Sunset Town to savor Phu Quoc’s culinary delights and enjoy street performances at the VuiFest Night Bazaar, watch an enchanting water puppet show at A Oi Theater, or capture memorable photos at the Kiss Bridge — Phu Quoc’s newest landmark. For those seeking vibrant nightlife, a complimentary shuttle bus is available to Duong Dong Town, where visitors can explore local restaurants and bars.

Located at Kem Beach – one of the top 100 most beautiful beaches in the world, guests staying at Premier Residences Phu Quoc can truly embrace the natural beauty of the "pearl island". The resort offers a diverse accommodation system with 752 units from rooms, suites, apartments, penthouses and villas, all with stunning views of the emerald coastline. From sunrise to sunset, guests can always enjoy breathtaking scenery throughout their stay.

Beach activities are an essential part of any vacation, offering both fun and opportunity for family bonding. Guests can embark on adventures on the sparkling waves with colorful kayaks or paddleboards, providing a unique perspective of the beautiful Kem Beach. These activities not only foster emotional connections among family members but also offer an intimate experience with the island’s natural beauty, featuring sunny skies, refreshing ocean breezes, and soft white sand.

The resort boasts one of the largest and longest pools in Southern Phu Quoc, thoughtfully divided into sections catering to various age groups. This ensures that families can enjoy perfect moments of relaxation together. While parents indulge in delectable snacks and sophisticated cocktails, they can watch their children revel in the water slides and vibrant floats.

Every Saturday afternoon, the pool area here transforms into a lively foam party venue, promising delightful fun and laughter for the entire family. Guests are invited to wear stylish sunglasses and vibrant swimwear to make the most of their photo opportunities in this lively setting.

With exceptional guest privileges and superior service quality, Premier Residences Phu Quoc stands out as an unmissable destination for families seeking a memorable year-end getaway.

Access our media kit HERE

Contact:

Email: [email protected]
Website: https://premierresidencesphuquoc.com/

Source : Discover Exclusive Privileges during The Stay at Premier Residences Phu Quoc

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

GURUGRAM, India and AHMEDABAD, India, Sept. 18, 2024 /PRNewswire/ — Hygenco Green Energies Pvt Ltd, a pioneer in producing low-cost green hydrogen, announced entering into a MOU with REC Limited (earlier Rural Electrification Corporation limited) for financing Hygenco’s Green Ammonia Project in Gopalpur, Odisha. The MOU was formalized during the 4th Global Re-Invest held in Gandhinagar, Gujarat.

Hygenco – REC Limited MOU signing at Gujarat, India

The company’s Green Ammonia Project is part of its broader vision to reduce carbon emissions. Under the MOU, REC will fund upto $280 million for the project, even as Hygenco is planning to invest about US$2.5 billion towards its green hydrogen and green ammonia projects across India in the next few years.

Amit Bansal, Co-Founder and CEO of Hygenco, said, "We are committed to energy security and aligning with the Indian government’s vision of Aatmanirbhar Bharat. Our projects will help reduce carbon emissions and pave the way for a sustainable future."

Hygenco has already made a name for itself in the green hydrogen space. In March 2024, Hygenco commissioned India’s first commercial green hydrogen plant in Hisar, Haryana. In 2022, Hygenco had signed India’s first-ever commercial long-term offtake agreement of green hydrogen for the Hisar based project with Jindal Stainless. The developer has also signed agreements with major companies including Sterlite Technologies to supply green hydrogen.

Hygenco’s goal is to become a global leader in green hydrogen and green ammonia solutions.

Hygenco’s success is a significant step towards reducing India’s carbon footprint. Their projects will help decarbonize industries that are difficult to abate, such as steel and chemical. This will contribute to India’s climate goals and help create a sustainable future.

About Hygenco:

Headquartered in Gurgaon, India, Hygenco develops and deploys scaled-up commercially attractive green hydrogen and green ammonia assets. Hygenco, which has deep capabilities in designing, building, and operating Green Hydrogen projects, has commissioned India’s first Green Hydrogen project in Hisar which was inaugurated by Union Minister of Civil Aviation and Steel earlier this year. Hygenco is looking to invest $2.5 billion over 3 years to set up Green Hydrogen projects in India.

For more information on Hygenco, please visit https://www.hygenco.in/.

Photo: https://mma.prnasia.com/media2/2507435/Hygenco.jpg?p=medium600
Logo: https://mma.prnasia.com/media2/2406450/Hygenco_Logo.jpg?p=medium600

Source : Hygenco enters into MOU with REC to finance Green Ammonia Project in Gopalpur, Odisha

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of a healthy, active, and mobile life

DUBAI, UAE and RIYADH, Saudi Arabia, Sept. 18, 2024 /PRNewswire/ — TVM Capital Healthcare, an international healthcare expansion and growth capital firm, today announced a recent equity investment in San Francisco-based Human Longevity, Inc. (HLI), a global leader since 2013 in advancing precision medicine in the pursuit of healthy aging, often referred to as longevity medicine. The investment will support the company’s growth within the U.S. market, as well as its expansion into the Kingdom of Saudi Arabia and Southeast Asia.

Founded by Dr. J. Craig Venter, one of the pioneers of the human genome sequencing effort, HLI builds on his vision for a longer, healthier life and the democratization of genomics to revolutionize the way we evade "avoidable disease" and stay healthy longer. The company is recognized as a leader in the rapidly expanding industry of longevity medicine due to its deep expertise in genomics and other fields of precision medicine such as imaging, and its unmatched, longitudinal patient dataset built on decades of research in the field. The company has proprietary tools for the detection of gene-disease associations, including HLI’s artificial intelligence health risk and recommendation platform, and provides its clients with pre-symptomatic diagnosis and customized treatments, preempting disease at a very early stage and maximizing health outcomes. In short, HLI is transforming healthcare from a reactive practice to one that is predictive, proactive, and preventative, which not only enhances the quality of lives of individuals but improves the efficiency and efficacy of the entire healthcare system.

TVM Capital Healthcare brings extensive global investment experience combined with operating experience in the Middle East and Southeast Asia and a track record of building innovative healthcare companies. Through this investment provided by the Saudi Arabia-focused TVM Healthcare Afiyah Fund LP, which closed earlier this year and is the largest growth capital fund of its kind in the region, the firm will support HLI in its expansion, initially with a special focus on market entry in the Kingdom. The country’s Vision 2030 and Health Sector Transformation Program call for an evolution of "sick care" to true "health care," focusing on the most critical fields of oncology, neurology, metabolic syndrome, and diabetes, as well as cardiovascular and autoimmune disease. Saudi Arabia is highly receptive to healthcare business models such as HLI and has been increasingly active in longevity science with several government-backed initiatives, including the Saudi Human Genome Program and the Hevolution Foundation, a Riyadh-headquartered global non-profit organisation, investing in scientific projects and life science companies in the longevity field.

Dr. J. Craig Venter, Co-Founder and Chief Scientific Advisor of Human Longevity, Inc., commented: "Human Longevity, Inc. is a health firm where the goal is to stay ahead of aging and illness. We believe this platform will save millions of lives and significantly reduce healthcare costs in the future. TVM Capital Healthcare’s investment enables us to strengthen our position globally as the most data-backed longevity practice, as well as establishes our foothold in markets, like Saudi Arabia and SEA, that see the potential of our approach in preventive medicine and the huge impact it will have on changing the cost of medicine."

Dr. Helmut M. Schuehsler, Chairman and CEO of TVM Capital Healthcare, remarked: "With our investment in HLI, we contribute to the transition towards the ‘healthcare of the future’ which is all about precision medicine, personalized care, and disease prevention, in short: true ‘health care.’  The potential long-term impact of longevity medicine in society is immense. We are excited to be part of the journey through this new investment which supports the growth of the company in the U.S., but also introduces HLI into the Kingdom of Saudi Arabia and Southeast Asia."

Dr. Ghida Harfouche, Partner at TVM Capital Healthcare, added: "HLI’s cutting-edge science has enabled precision medicine for disease prevention and highly personalized interventions for their clients. We are pleased we can support the company in its global growth, and work with them on democratization of healthy longevity and preventative care."

TVM Capital Healthcare is recognized as the first international Healthcare fund manager investing in and operating healthcare companies in the Kingdom of Saudi Arabia. The firm is also active across the wider Middle East and Southeast Asia. In addition to backing healthcare growth companies in the U.S. and Europe to support their expansion plans into these regions, TVM Capital Healthcare also invests in leading local companies. With this two-pronged, highly catalytic strategy, TVM Capital Healthcare improves quality and affordable access to world-leading products, technologies, and services across its target markets.

ENDS

About TVM Capital Healthcare

TVM Capital Healthcare is a global healthcare private equity firm specializing in emerging markets. Based in Dubai and Singapore, with offices in Riyadh and Ho Chi Minh City, the firm invests expansion and growth capital in healthcare companies to improve local access to quality and affordable care, as well as local sources of medical products in the pharma, medical device, and diagnostics sectors. Investment and operating partners, as well as a strong group of regional and international senior advisors, have long-standing track records in healthcare investing and deep operating experience in the Middle East and Southeast Asia.

Medical quality is safeguarded by collaborations with leading international medical technology and clinical partners such as Mass General Hospital as well as international accreditation agencies such as Joint Commission International (JCI). TVM Capital Healthcare’s investment and operating approach combines strong commercial value creation and financial returns with responsible and sustainable investment in alignment with the United Nations Sustainable Development Goals. Our proven strategy in the critical sector of healthcare also includes climate adaptation and resilience.www.tvmcapitalhealthcare.com

Contact:

Holly Radel
[email protected] 

Logo – https://mma.prnasia.com/media2/1446186/2740341/TVM_Capital_Healthcare_Logo.jpg?p=medium600 

Source : TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of a healthy, active, and mobile life

DUBAI, UAE and RIYADH, Saudi Arabia, Sept. 18, 2024 /PRNewswire/ — TVM Capital Healthcare, an international healthcare expansion and growth capital firm, today announced a recent equity investment in San Francisco-based Human Longevity, Inc. (HLI), a global leader since 2013 in advancing precision medicine in the pursuit of healthy aging, often referred to as longevity medicine. The investment will support the company’s growth within the U.S. market, as well as its expansion into the Kingdom of Saudi Arabia and Southeast Asia.

Founded by Dr. J. Craig Venter, one of the pioneers of the human genome sequencing effort, HLI builds on his vision for a longer, healthier life and the democratization of genomics to revolutionize the way we evade "avoidable disease" and stay healthy longer. The company is recognized as a leader in the rapidly expanding industry of longevity medicine due to its deep expertise in genomics and other fields of precision medicine such as imaging, and its unmatched, longitudinal patient dataset built on decades of research in the field. The company has proprietary tools for the detection of gene-disease associations, including HLI’s artificial intelligence health risk and recommendation platform, and provides its clients with pre-symptomatic diagnosis and customized treatments, preempting disease at a very early stage and maximizing health outcomes. In short, HLI is transforming healthcare from a reactive practice to one that is predictive, proactive, and preventative, which not only enhances the quality of lives of individuals but improves the efficiency and efficacy of the entire healthcare system.

TVM Capital Healthcare brings extensive global investment experience combined with operating experience in the Middle East and Southeast Asia and a track record of building innovative healthcare companies. Through this investment provided by the Saudi Arabia-focused TVM Healthcare Afiyah Fund LP, which closed earlier this year and is the largest growth capital fund of its kind in the region, the firm will support HLI in its expansion, initially with a special focus on market entry in the Kingdom. The country’s Vision 2030 and Health Sector Transformation Program call for an evolution of "sick care" to true "health care," focusing on the most critical fields of oncology, neurology, metabolic syndrome, and diabetes, as well as cardiovascular and autoimmune disease. Saudi Arabia is highly receptive to healthcare business models such as HLI and has been increasingly active in longevity science with several government-backed initiatives, including the Saudi Human Genome Program and the Hevolution Foundation, a Riyadh-headquartered global non-profit organisation, investing in scientific projects and life science companies in the longevity field.

Dr. J. Craig Venter, Co-Founder and Chief Scientific Advisor of Human Longevity, Inc., commented: "Human Longevity, Inc. is a health firm where the goal is to stay ahead of aging and illness. We believe this platform will save millions of lives and significantly reduce healthcare costs in the future. TVM Capital Healthcare’s investment enables us to strengthen our position globally as the most data-backed longevity practice, as well as establishes our foothold in markets, like Saudi Arabia and SEA, that see the potential of our approach in preventive medicine and the huge impact it will have on changing the cost of medicine."

Dr. Helmut M. Schuehsler, Chairman and CEO of TVM Capital Healthcare, remarked: "With our investment in HLI, we contribute to the transition towards the ‘healthcare of the future’ which is all about precision medicine, personalized care, and disease prevention, in short: true ‘health care.’  The potential long-term impact of longevity medicine in society is immense. We are excited to be part of the journey through this new investment which supports the growth of the company in the U.S., but also introduces HLI into the Kingdom of Saudi Arabia and Southeast Asia."

Dr. Ghida Harfouche, Partner at TVM Capital Healthcare, added: "HLI’s cutting-edge science has enabled precision medicine for disease prevention and highly personalized interventions for their clients. We are pleased we can support the company in its global growth, and work with them on democratization of healthy longevity and preventative care."

TVM Capital Healthcare is recognized as the first international Healthcare fund manager investing in and operating healthcare companies in the Kingdom of Saudi Arabia. The firm is also active across the wider Middle East and Southeast Asia. In addition to backing healthcare growth companies in the U.S. and Europe to support their expansion plans into these regions, TVM Capital Healthcare also invests in leading local companies. With this two-pronged, highly catalytic strategy, TVM Capital Healthcare improves quality and affordable access to world-leading products, technologies, and services across its target markets.

ENDS

About TVM Capital Healthcare

TVM Capital Healthcare is a global healthcare private equity firm specializing in emerging markets. Based in Dubai and Singapore, with offices in Riyadh and Ho Chi Minh City, the firm invests expansion and growth capital in healthcare companies to improve local access to quality and affordable care, as well as local sources of medical products in the pharma, medical device, and diagnostics sectors. Investment and operating partners, as well as a strong group of regional and international senior advisors, have long-standing track records in healthcare investing and deep operating experience in the Middle East and Southeast Asia.

Medical quality is safeguarded by collaborations with leading international medical technology and clinical partners such as Siemens Healthineers and Mass General Hospital as well as international accreditation agencies such as Joint Commission International (JCI).) TVM Capital Healthcare’s investment and operating approach combines strong commercial value creation and financial returns with responsible and sustainable investment in alignment with the United Nations Sustainable Development Goals. Our proven strategy in the critical sector of healthcare also includes climate adaptation and resilience.www.tvmcapitalhealthcare.com

Contact:

Holly Radel
[email protected] 

Source : TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Eight out of 10 Asian tech professionals recognise UAE’s growing reputation as a tech hub; 45% of tech workers would relocate to the UAE, outperforming Germany and Hong Kong as a popular relocation destination for tech talent; 93% of respondents think it is important to have a government that is supportive of the tech industry

DUBAI, UAE, Sept. 18, 2024 /PRNewswire/ — A recent survey conducted by Capital.com, a global trading platform and the Middle East’s fastest-growing technology company*, has revealed that the United Arab Emirates (UAE) is rapidly gaining recognition as a competitive tech hub. The survey polled 1,000 respondents across Singapore, Hong Kong, Vietnam and India, and found that 81% of Asian tech professionals view the UAE as a growing tech hub. A further 76% of respondents say the UAE provides a conducive environment for the tech industry.

Tarik Chebib, CEO, Middle East, Capital.com

The UAE’s growing reputation as a burgeoning tech hub is fuelling interest among tech workers across the region, with nearly half (45%) of respondents expressing a willingness to relocate to the UAE for work, out-ranking countries like Germany (38%) and Hong Kong (20%) as popular relocation destinations.

This places the UAE in close competition with other prominent destinations such as Singapore (46%), the UK (57%), and the US (52%) as preferred locations for relocation among tech professionals.

Commenting on the findings, Tarik Chebib, CEO, Capital.com, Middle East, said:

"With 8 in 10 respondents from our recent survey recognising the UAE as a competitive tech hub, it’s clear that the region is gaining momentum as a favourable destination for tech talent. Asia’s tech professionals have traditionally gravitated to cities in the UK, the US and Singapore to further their careers, so it’s encouraging to see the UAE stand shoulder-to-shoulder with this cohort and get the recognition it deserves as an attractive location to live and work."

Government support is the key factor contributing to UAE’s growing reputation as a tech hub and relocation destination of choice. Of those surveyed, 93% think it is important to have a government that is supportive of the tech industry, highlighting the UAE’s concentrated push to develop the country as a hotspot for international tech talent. 

The majority of those surveyed (74%) cite the UAE’s banking, visa, special healthcare/health insurance packages, and real estate services for qualified tech professionals, as factors. More broadly, respondents also say that a high quality of life (60%), attractive remuneration (54%) and the UAE’s strategic location (52%) also feed into their decision to relocate.

"As a leading partner of the UAE’s NextGenFDI initiative, we have seen first-hand the government’s commitment to support and grow the tech sector. The UAE’s business-friendly environment, forward-thinking policies, investment in innovation, and position as a gateway to the Middle East, Africa and Asia, makes it an ideal location for companies and talent alike. Capital.com is proud to contribute to the sector’s growth and innovation in the UAE." said Chebib.

While all respondents indicated a ‘willingness’ to relocate for work, 47% indicated that they are ‘actively’ looking to relocate, highlighting the huge potential for the UAE to attract and retain tech talent.

"As a company operating in the UAE that is licensed by the Securities and Commodities Authority (SCA), we need to draw on an exceptional pool of talent to meet our exacting business and regulatory needs. This means searching for the best talent, from anywhere in the world. Given the UAE’s pro-talent stance and growing appeal as a tech destination for professionals, we have had no problem recruiting talent from as far afield as the UK, Europe and Australia. Employees are eager to relocate to a country that not only supports their personal needs but also provides fertile ground for further development within the tech sector," added Chebib.

Capital.com opened its UAE subsidiary and regional headquarters in March 2024. Based in Dubai, Capital Com MENA Securities Trading LLC (Capital Com MENA), is licensed and regulated by the UAE Securities and Commodities Authority (SCA). Capital.com is also a leading member of the UAE’s #NextGenFDI initiative, a government-led initiative enabling cutting-edge companies from around the world to establish and expand their operations in the UAE. In 2022, Capital.com was a sponsor of the UAE’s NextGen Talent initiative, which was aimed at developing the capabilities of local youth and preparing future leaders in the technology sector.

Survey methodology:

The survey was carried out between 11 and 28 July 2024 and fielded responses from 1,000 respondents who currently work in a variety of tech-related roles in Singapore, Hong Kong, Vietnam or India, and had declared they were open to relocating to another country for work. The sample split was 250 respondents from Hong Kong, 250 respondents from Singapore, 250 respondents from Vietnam, and 250 respondents from India.  

Notes to Editors

About Capital.com:

Capital.com enables clients to trade derivatives on more than 3,000 of the world’s most popular indices, commodities, cryptocurrencies, shares, and currency pairs. In addition to its web and mobile-based platforms, Capital.com also provides clients with access to free education and trading tools to help them hone their trading knowledge.

As a global fintech company with offices in London, Dubai, Limassol, Melbourne, Warsaw, and Vilnius, Capital.com is guided by a sustainability-led startup framework, prioritising smart partnerships with the public and private sector to help drive progress and sustainable growth.

Capital Com (UK) Limited is authorised and regulated by the Financial Conduct Authority (FCA) under registration number 793714. Capital Com SV Investments Limited is Authorised and regulated by the Cyprus Securities and Exchange Commission (CySEC), under licence number 319/17. Capital Com Australia Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) under AFSL Number 513393. Capital Com Online Investments Ltd is a Company registered in the Commonwealth of The Bahamas and authorised to carry out Securities Business by the Securities Commission of The Bahamas with licence number SIA-F245. Capital Com Mena Securities Trading LLC is authorised and regulated by the Securities and Commodities Authority (SCA), under license number 20200000176.

To find out more, please visit:  www.capital.com

This press release is for media use only. It’s not intended for individual investors, and doesn’t include personal advice or recommendations.

DISCLAIMER

Spread bets and/or CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 83.51% of retail investor accounts lose money when trading spread bets and/or CFDs with this provider. You should consider whether you understand how spread bets and/or CFDs work and whether you can afford to take the high risk of losing your money. Professional clients can lose more than they deposit. All trading involves risk.

Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd. Spread bets are available only to UK clients.

The value of shares and ETFs bought through a share dealing account can fall as well as rise, which could mean getting back less than you originally put in. Past performance is no guarantee of future results.

Capital Com (UK) Limited ("CCUK") is registered in England and Wales with company registration number 10506220. CCUK is authorised and regulated by the Financial Conduct Authority ("FCA"), under registration number 793714. Capital Com SV Investments Limited ("CCSV") is registered in Cyprus with company registration number 354252. CCSV is regulated by Cyprus Securities and Exchange Commission (CySEC) under licence number 319/17. Capital Com Australia Pty Ltd is authorised and regulated by the Australian Securities and Investments Commission (ASIC) under AFSL Number 513393. Capital Com Online Investments Ltd is a limited liability company (company number 209236B) registered in the Commonwealth of The Bahamas and authorised to carry on Securities Business by the Securities by the Securities Commission of The Bahamas ("SCB") with licence number SIA-F245. Capital Com Mena Securities Trading LLC is authorised and regulated by the Securities and Commodities Authority (SCA), under license number 20200000176.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as "investment research" has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.

Source : New survey finds UAE emerging as a global tech hub for Asian talent

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Join Industry Leaders & Channel Experts for a Fun, High-Quality Omnichannel Education Experience

ATLANTA, Sept. 18, 2024 /PRNewswire/ — Sinch Sinch AB (publ) – (XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, is excited to announce the return of its highly anticipated event, Email Camp. The free 3-day virtual event will take place from September 24-25, running each day from 9:00 am to 12:30 pm CST, featuring on-demand sessions each day.

Sinch’s Email Camp MessageMania is designed to bring together the best in email, SMS, RCS, and beyond, featuring top industry leaders and channel experts who will delve into the latest trends, strategies, and innovations. Last year, over 6,500 email professionals registered for the 3-day event, experiencing unparalleled learning and networking opportunities.

Key Highlights of Email Camp 2024:

32 Expert Training Sessions: Featuring insights from companies like Sinch, Miro, and Hims & Hers. Live Q&A Sessions: Engage with omnichannel experts in real-time. Future of AI in Messaging: Get a glimpse into the innovations transforming the industry. Networking Opportunities: Connect with over 6,500 fellow attendees.

"MessageMania is a unique opportunity for professionals to immerse themselves in the latest trends and best practices in email and omnichannel marketing," shared Gwen Lafage, Vice President of Brand at Sinch. "At Sinch we are committed to providing not only the best tools but also the highest quality education to help our customers succeed."

Sinch is renowned for its suite of email solutions, including Sinch Mailgun, Sinch Mailjet, and Sinch Email on Acid, providing the perfect fit for developers, product teams, and marketers. Sinch’s messaging infrastructure scales to send over 450 billion emails annually with a 99.99% uptime and can deliver 15 million messages within hours.

By attending Sinch’s Email Camp, participants will gain valuable insights from industry leaders and also have the opportunity to network with peers and learn how to optimize their communications strategies for maximum impact.

For more information and/or to register visit Sinch’s Email Camp

For further information, please contact: 
Janet Lennon, Director of Global PR & Communications
[email protected]
1-206-914-6175

This information was brought to you by Cision http://news.cision.com

Source : Sinch Email Camp Returns: Get Ready for MessageMania

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network